Co-lead, Exercise and Genitourinary Cancers Research Group
Professor Daniel Galvão is Director of the Exercise Medicine Research Institute at Edith Cowan University, Australia, and Fellow of the American College of Sports Medicine and Exercise and Sports Science Australia. Galvão’s research program developed and tested targeted exercise interventions to reverse treatment-related toxicities and improve patient outcomes that have changed the clinical management of cancer patients worldwide. His research support includes >$25 million in continuing external funding over the past 15 years from the NHMRC, Prostate Cancer Foundation of Australia, Cancer Australia, Cancer Council Western Australia, and Movember Foundation.
Professor Galvão has published over 200 refereed journal papers in exercise medicine/oncology listed on Scopus and is an author of influential national and international guidelines for exercise in cancer patients including Exercise and Sports Science Australia (2009, 2019) and American College of Sports Medicine (2010, 2019). As a direct result, international clinical recommendations changed for individuals to avoid inactivity and return to normal activity as soon as possible after cancer diagnosis or treatment. Professor Galvão has served on numerous national research committees including NHMRC Grant review panels, Prostate Cancer Foundation of Australia Research Advisory Committee, and Cancer Council of Western Australia for over a decade.
Selected Publications
- Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005 Feb 1;23(4):899-909. Impact Factor: 44.544.
- Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010 Jan 10;28(2):340-7. Impact Factor: 44.544.
- Newton RU, Taaffe DR, Chambers SK, Spry N, Galvão DA. Effective Exercise Interventions for Patients and Survivors of Cancer Should be Supervised, Targeted, and Prescribed With Referrals From Oncologists and General Physicians. J Clin Oncol. 2018 Mar 20;36(9):927-928. PubMed PMID: 29373097. Impact Factor: 44.544.
- Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Chambers SK, Newton RU. A multicentre year-long randomized controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. European Urology. 2014;65(5):856-64. Impact Factor: 20.096.
- Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall B, Cormie P, Bolam KA, Galvão DA. Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial. European Urology, 2017 Aug;72(2):293-299. Impact Factor: 20.096.
- Newton RU and Galvão DA. Accumulating Evidence for Physical Activity and Prostate Cancer Survival: Time for a Definitive Trial of Exercise Medicine? European Urology, 2016 Oct;70(4):586-587. Impact Factor: 20.096.
- Schmitz KH, Campbell A, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, Ligibel JA, Cheville A, Galvão DA et al. Exercise Is Medicine in Oncology: Engaging clinicians to help patients move through cancer. CA: A Cancer Journal for Clinicians. 2019 Nov;69(6):468-484. Impact Factor 508.702.
- Galvão DA, Taaffe DR, Spry N, Gardiner RA, Taylor R, Risbridger G, Frydenberg M, Hill M, Chambers SK, Stricker P, Shannon T, Hayne D, Zopf E, Newton RU. Enhancing Active Surveillance for Men with Prostate Cancer: The Potential Role of Exercise Medicine. Nature Reviews Urology 2016. 2016 May;13(5):258-65. Impact Factor: 14.432.
- Buffart L, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, Galvão DA et al. Targeting exercise interventions to patients with cancer in need: an individual patient data meta-analysis. JNCI: Journal of the National Cancer Institute. 2018 Nov 1;110(11):1190-1200. Impact Factor: 13.506.
- Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvão DA et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017 Jan;52:91-104. Impact Factor: 12.111.
Research Funding
Continuing external funding over the past 20 years (selected from 73 grants >$26 million in total funded).
- 2024 - 2027 - World Cancer Research Funds International. $534,961.
- 2022 - 2027 - MRFF, Rare Cancers. $561,910.
- 2021 - 2025 - National Health and Medical Research Council. Partnership Project. $2,604,576.
- 2021 - 2026 - Cancer Council WA Prostate Cancer Research Initiative. $472,739.
- 2018 - 2024 - National Health and Medical Research Council. Project. $596,083.
- 2016 - 2024 - National Health and Medical Research Council. Centre for Research Excellence (CRE) Prostate Cancer Survivorship. $2,498,842.
- 2016 - 2025 - Movember GAP4. Trial coordination. $701,494.
- 2016 - 2024 - Movember GAP4. Project. $635,910.
- 2014 - 2017 - National Health and Medical Research Council. Project. $561,845.
- 2014 - 2017 - Cancer Council Western Australia Research Fellowship. $320,000.
- 2012 - 2014 - Cancer Australia. Project. $446,276.
- 2012 - 2013 - Prostate Cancer Foundation of Australia. Project. $296,820.
- 2011 - 2014 - Australian Collaborative Research Networks Program. $988,188.
- 2011 - 2013 - Cancer Australia/Beyond Blue. Project. $598,194.
- 2009 - 2012 - Prostate Cancer Foundation of Australia. Project. $476,024.
- 2009 - 2011 - National Health and Medical Research Council. Project. $500,000.
- 2007 - 2008 - Prostate Cancer Foundation of Australia. Project. $244,328.
Professional and contributions to NHMRC
- NHMRC Grant Review Panel (GRP) Member Clinical Trials and Cohort Studies (CTCs) (2023).
- NHMRC Grant Review Panel (GRP) Member Clinical Trials and Cohort Studies (CTCs) (2022).
- NHMRC Grant Review Panel (GRP) Member Clinical Trials and Cohort Studies (CTCs) (2021).
- NHMRC Grant Review Panel (GRP) Member Clinical Trials and Cohort Studies (CTCs) (2019).
- NHMRC Grant Review Panel (GRP) Member Project Grants Clinical Medicine and Musculoskeletal 2012.
- NHMRC Grant Review Panel (GRP) Member Project Grants Musculoskeletal 2011.
- NHMRC Australian Prostate Cancer Research Centres Review Committee Member (2016).
- NHMRC Australian Prostate Cancer Research Centres Review Committee Member (2015).
- National Research Advisory Committee. Prostate Cancer Foundation of Australia (2020-2024).
- Cancer Council of Western Australia Research Committee Member (2009-2021).
- Chair of the Research Grants Pre-Doctoral Sub-committee of the Cancer Council of WA (2013-2016).
- Chair of the Prostate Cancer Foundation of Australia John Mills Young Investigator Research Award (2017).
- Project grant applications for various international research agencies including USA, UK, Canada, Germany, Denmark, Italy, England and the Netherlands.
- Regular reviewer for 40+ journals (e.g. Journal of Clinical Oncology > 20 times, Prostate Cancer and Prostatic Diseases > 20 times).
Academic Positions
- 2018 - current: Director, Exercise Medicine Research Institute, Edith Cowan University, WA, Australia.
- 2015 - current: Co-Director, Exercise Medicine Research Institute, Edith Cowan University, WA, Australia.
- 2015 Jul - Dec: Visiting Research Fellow, German Sport University Cologne [Deutsche Sporthochschule Köln], Cologne, Germany.
- 2014 - 2015: Co-Director, Edith Cowan University Health and Wellness Institute, Edith Cowan University, WA, Australia
- 2014 - 2017: Cancer Council Western Australia Research Fellow
- 2012 - current: Professor of Exercise and Sports Science, Edith Cowan University Health and Wellness Institute, WA, Australia.
- 2010 - 2013: Director, Edith Cowan University Health and Wellness Institute, Edith Cowan University, WA, Australia.
- 2010 - 2012: Associate Professor of Exercise and Sports Science, School of Exercise and Health Sciences, Edith Cowan University, WA, Australia.
- 2009 - 2010: Acting Director, Vario Health Institute, Edith Cowan University, WA, Australia.
- 2009 - 2010: Senior Research Fellow - School of Exercise, Biomedical and Health Sciences, Edith Cowan University, WA, Australia.
- 2007 - 2008: Post-Doctoral Research Fellow, School of Exercise, Biomedical and Health Sciences and Vario Health Institute, Edith Cowan University, WA, Australia.
- 2006 - 2007: Post-Doctoral Research Fellow, Centre of Excellence for Alzheimer’s Disease Research and Care, Edith Cowan University, WA, Australia.
Awards and Recognitions
- 2021 - Asian Pacific Prostate Cancer Conference 2021 for best poster Schumacher et al. Effects of exercise during radiotherapy on physical function and treatment-related side effects in men with prostate cancer.
- 2015 - Prostate Cancer World Conference Award for best paper in Allied Health category, for Hart et al. Musculoskeletal comparisons of prostate cancer patients with localised versus metastatic disease progression.
- 2014 - Edith Cowan University Vice-Chancellor's Award for Excellence in Research.
- 2014 - 21st Hong Kong International Cancer Congress, Li Ka Shin Faculty of Medicine, Hong Kong University best poster in psychosocial oncology for M Tse et al. Study protocol for exercise as medicine for men with prostate cancer in Hong Kong - a randomized controlled trial.
- 2014 - Edith Cowan University one of the most highly cited researchers in the past 5 years.
- 2013 - Prostate Cancer World Conference Award for best paper in Allied Health category, for Newton et al. Can exercise prevent treatment toxicity in prostate cancer patients initiating androgen suppression therapy: a randomised controlled trial.
- 2012 - Western Australia Tall Poppy Scientist of the Year 2012. Australian Institute of Policy and Science
- 2011 - Finalist Western Australia Science Awards, Early Career Scientist of the Year The Government of Western Australia.
- 2011 - Edith Cowan University’s top Research Activity Index performer for the year of 2010.
- 2011 - Second prize at Australasian Prostate Cancer Conference Poster Award for Urology Category, for: Peddle-McIntyre, et al. Presented at 12th Australasian Prostate Cancer Conference, Melbourne, Australia.
- 2010 - Edith Cowan University’s Top Research Activity Index performer for the year of 2009.
- 2009 - Government of Western Australia Department of Health. New Independent Researcher Infrastructure Support (NIRIS) Award. 2009. (Award $10,000).
- 2009 - ECU Vice-Chancellor’s Award for Research by Early Academics.
- 2009 - Australian Sports Medicine Federation Fellows Award Highly Commended Paper in the Category of Performance Enhancement and Basic Science. Be Active, Brisbane, 14-17 October 2009.
- 2007 - Exercise Sports Science Australia (ESSA) Medal for Most Outstanding PhD Thesis in Australia.
- 2007 - The Cancer Council of Western Australia first launched Early Career Investigator Grant.
- 2004 - Young Investigator Award at the Pre-Olympic Conference - International Council of Sport Science and Physical Education Development Award, Thessaloniki, Greece.
- 2003 - Journal of Science and Medicine in Sport Award for Best Poster Injury Prevention and Health Promotion Australian Association of Science and Medicine in Sport at the Australian Conference of Science and Medicine in Sport, Canberra, Australia.
- 2003 - Short listed for the Ken Maguire Award for best young investigator (Clinical Exercise) Australian Association of Science and Medicine in Sport at the Australian Conference of Science and Medicine in Sport, Canberra, Australia.
Research Areas and Interests
- Applications of exercise as medicine for the prevention and management of cancer treatment side-effects and survival.
Professional Memberships
- Fellow American College of Sports Medicine (FACSM)
- Fellow Exercise and Sports Science Australia (FESSA)
- American Society of Clinical Oncology (ASCO)
- Australian & New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- Primary Care Collaborative Cancer Clinical Trials Group (PC4)
- Member Australia Institute of Company Directors